NYSE · Drug Manufacturers - General

MRK (MRK) Stock

$149.59 +1.24% NYSE: MRK Healthcare

Valuation

MetricValue
Price$149.59
Market Cap$369.46B
P/E Ratio121.55
P/B Ratio9.03
P/S Ratio5.70
EPS (TTM)$7.28
52-Week High$156.92
52-Week Low$77.58
Dividend Yield2.22%

Financials & Margins

MetricValue
ROE6.60%
ROA2.44%
ROCE10.83%
Gross Margin41.19%
Operating Margin41.19%
Net Margin4.78%
Debt/Equity1.29
Current Ratio1.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$48.7B$59.3B$60.1B$64.2B$64.9B
Operating Profit$13.2B$18.3B$3.0B$20.2B$23.5B
Net Profit$13.0B$14.5B$365.0M$17.1B$18.3B
EPS$5.14$5.71$0.14$6.74$7.28
Op Margin27.1%30.8%4.9%31.5%36.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$105.7B$109.2B$106.7B$117.1B$136.9B
Total Liabilities$67.4B$63.1B$69.0B$70.7B$84.2B
Cash$8.1B$12.7B$6.8B$13.2B$14.6B
Borrowings$34.6B$32.0B$36.3B$38.3B$50.5B

Latest News

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says MT Newswires · Jul 10, 2026 JNJ Stock Keeps Climbing. Should You Climb On? Trefis · Jul 10, 2026 Berenberg Adjusts Price Target on Merck to $127 From $125, Keeps Hold Rating MT Newswires · Jul 10, 2026 This Blue-Chip Dividend Stock Is Outperforming the S&P 500 in 2026 Barchart · Jul 9, 2026 EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth? Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$14.1B$19.1B$13.0B$21.5B$16.5B
Investing Cash Flow$-21.0B$-9.3B$-17.9B$-11.1B$-17.9B
Financing Cash Flow$7.6B$-240.0M$-1.5B$-1.5B$-5.2B
Net Cash Flow$14.0M$4.6B$-5.9B$6.4B$1.4B
Free Cash Flow$9.7B$14.7B$9.1B$18.1B$12.4B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.51
EV / EBITDA30.72
FCF Yield4.25%
Quick Ratio1.10
Interest Coverage8.75
Return 1Y84.24%
Return 3Y47.93%
Return 5Y96.01%

Ownership

Insiders Held0.06%
Institutions Held82.24%
Institutions Float Held82.29%
Institutional HolderSharesReport Date
Blackrock Inc.225,830,3302026-03-31
Vanguard Capital Management LLC160,987,6242026-03-31
State Street Corporation119,325,6732026-03-31
Wellington Management Group, LLP84,314,9712026-03-31
Vanguard Portfolio Management LLC67,304,3052026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABT $109.49 -0.79% 36.69 $189.46B 2.21%
AMGN $435.89 +1.40% 27.15 $235.25B 2.29%
AZN $161.96 -0.10% 24.78 $251.18B 1.28%
GILD $148.94 +1.78% -56.96 $184.92B 2.21%
GSKGSK plc $51.58 9.28 $103.73B 3.49%

About MRK

MRK is led by CEO Robert Davis, employs 73,000 people, headquartered in Rahway, US, publicly traded since 1978.

MRK stock trades at $149.59 with a market capitalization of $369.46B. The stock is valued at a price-to-earnings (P/E) ratio of 121.55, price-to-book of 9.03, price-to-sales of 5.70. Over the past 52 weeks the stock has ranged between $77.58 and $156.92, and currently trades 4.7% below its 52-week high. It pays a dividend yielding 2.22%.

On profitability, MRK generates a return on equity (ROE) of 6.60%, return on capital employed of 10.83%, an operating margin of 41.19%, a net profit margin of 4.78%.

In its most recent fiscal year, MRK reported annual revenue of $64.9B, net profit of $18.3B, revenue has compounded at 9.4% a year over the last five years, profit at 20.9% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 1.29, a current ratio of 1.54, total assets of $136.9B, $14.6B in cash and equivalents.

MRK has an average daily trading volume of 10,298,837 shares, a beta of 0.21 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1161.39 +0.40% JNJ Drug Manufacturers - General $270.47 +1.74% ABBV Drug Manufacturers - General $260.17 +1.46% UNH Medical - Healthcare Plans $396.10 +1.72% NVS Drug Manufacturers - General $161.48 +6.19% AZN Drug Manufacturers - General $161.96 -0.10% AMGN Drug Manufacturers - General $435.89 +1.40% TMO Medical - Diagnostics & Research $601.51 -2.53% NVO Biotechnology $45.17 -0.35% ABT Medical - Devices $109.49 -0.79% GILD Drug Manufacturers - General $148.94 +1.78% PFE Drug Manufacturers - General $28.49 +0.09%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides